BfArM — authorised 12 November 2021
- Marketing authorisation holder: ROCHE REGISTRATION GMBH
- Status: approved
🇩🇪 IMDEVIMAB in Germany
BfArM authorised IMDEVIMAB on 12 November 2021
Marketing authorisation
IMDEVIMAB in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Germany
Frequently asked questions
Is IMDEVIMAB approved in Germany?
Yes. BfArM authorised it on 12 November 2021.
Who is the marketing authorisation holder for IMDEVIMAB in Germany?
ROCHE REGISTRATION GMBH holds the German marketing authorisation.